For American patients to be put first, DIR fee relief is essential

The following was a post Monday from NACDS president and chief executive officer Steven Anderson on Medium urging action on DIR fee relief in final Medicare rule: We may be just days from learning whether a pending Medicare rule will provide relief from pharmacy direct and indirect remuneration (DIR) fees, and thus live up to the

Contextualizing the value of retail Rx

A quarter century ago, it was unusual to have flu shots and other vaccinations administered in a retail pharmacy setting. Only a handful of states allowed the practice, and many conservative physicians and other traditionalists argued against extending pharmacists’ authority to immunize to additional jurisdictions. Despite the opposition, remaining barriers fell fairly quickly. Today community

How to get out from the suffocating miasma of DIR fees

The direct and indirect remuneration (DIR) component of Medicare Part D programs today is very complicated and has been implemented in a variety of ways. The lack of clarity, fairness and transparency to all parties has created business challenges for pharmacies. The National Association of Chain Drug Stores is working on behalf of pharmacies to

Consumers embrace new healthy living mindsets

It’s hard to miss the heightened shopper interest in health and wellness these days. In our recent “How America Shops” study, The Big Business of WELL, many shoppers showed they are committed to being well: 42% said that while it costs more to “live healthy,” it’s worth it. The study reveals they are willing to

Sera Labs: a thriving CBD company with a difference

LOS ANGELES — The retail market for products containing CBD is projected to expand rapidly in the coming years amid the growing acceptance of hemp and cannabis across the country. One of the up-and-coming companies in this category is Sera Labs. With more than 30 years of experience working as an entrepreneur with a passion

The profit pool for U.S. prescription drugs is shrinking

For the past few years, the United States has been wrestling with the cost of health care. Our system is shifting toward outcomes-based payment models, and falling reimbursements are encouraging efficiency. As the industry seeks and implements lower-cost models, health care profitability is under pressure throughout the prescription drug value chain. To shed light on

CBD’s place in the chain drug merchandise mix

Two thousand eighteen may be remembered in retail marketing history as the year discussing CBD moved from Bon-naroo to the board room.  Extensive media coverage; legalization of all forms of cannabis in Canada and parts of the U.S.; a tsunami of benefit claims; a flood of new CBD products across a broad spectrum of categories;

A retailer at heart should lead Rite Aid

A new phase in Rite Aid’s two-decade-long quest to fully recover from the criminal financial irregularities that pushed it to the brink of bankruptcy in the late 1990s began last month with top-level management changes and an organizational realignment designed to, in the words of Bruce Bodaken, chairman of the drug chain’s board of directors,

Mile High Labs raises $65mm to purchase mountains of hemp

BOULDER, Colo. — Mile High Labs, the largest extractor of CBD in the world, achieved another historic financing event with the close of a $65mm term loan facility, one of the largest non-dilutive capital raises in the sector to date. The financing comes on the heels of the largest Series A equity raise in cannabis market

Williams appointed CEO at PepsiCo Foods North America

PURCHASE, N.Y. — PepsiCo Friday announced that Steven Williams, currently senior vice president and chief commercial officer for Frito-Lay’s U.S. operations, has been appointed to the role of chief executive officer of PepsiCo Foods North America (PFNA), which includes Frito-Lay North America (FLNA) and Quaker Foods North America (QFNA), effective immediately.  Williams replaces Vivek Sankaran who will

House introduces legislation to bolster consumer health savings

WASHINGTON — The Consumer Healthcare Products Association (CHPA) applauds the introduction of the Restoring Access to Medication Act. The bipartisan legislation would reinstate consumers’ ability to purchase over-the-counter (O-T-C) medicines with tax-preferred savings accounts, including Flexible Spending Arrangements (FSAs) and Health Savings Accounts (HSAs). The legislation, authored by Representatives Ron Kind (D, Wis.), Grace Meng (D, N.Y.),

Irwin Naturals appoints Tim Toll CEO

LOS ANGELES— Earlier this year, Klee Irwin, owner and founder of Irwin Naturals, named Timothy Toll chief executive officer. This move comes at a time of rapid growth for Irwin Naturals, a leading health and wellness company with a long history of providing its customers with quality and affordable health supplements spearheaded by its flagship brand of all-liquid

Washington, Michigan and Wisconsin see more flu activity

Washington, Michigan and Wisconsin see more flu activity

DEERFIELD, Ill.— Washington, Michigan and Wisconsin were the lead states in Walgreens Flu Index for week ending March 16, 2019. The Walgreens Flu Index is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranks those states and markets experiencing the highest incidences of influenza across the country. Now in its

Theraworx Relief getting high marks for pain relief

Theraworx Relief getting high marks for pain relief

ASHEVILLE, N.C. — One of the fastest-growing brands in the pain management category has been Avadim Health Inc.’s popular topical solution for spasms and cramps, Theraworx. Ralph Lombardo, Avadim Health’s senior vice president of sales and marketing, notes that the brand has been well received since it was launched nationwide in 2017. “Theraworx Relief Foam